Karius is a life sciences company focused on conquering infectious diseases through the innovative use of next-generation sequencing to analyze microbial cell-free DNA. The company’s genomics platform enables the broad and rapid detection of more than 1,250 pathogens and returns results within one business day, empowering doctors to rapidly diagnose infections, provide more targeted treatment, and spare patients the pain and risks of invasive biopsies.